Genetic Markers in Psychiatry

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Psychiatric disorders including addiction, depression, eating disorders, schizophrenia, and PTSD are complex, multifactorial conditions with significant public health and social impact.
• The neurobiological underpinnings of these disorders remain incompletely understood, hindering the identification of genetic markers.
• Current understanding of molecular imbalances contributing to these disorders is insufficient for effective genetic marker discovery.

Purpose of the Study:

• To propose novel genetic approaches using systems biology to identify biological underpinnings of psychiatric disorders.
• To explore the potential of combining genomics and epigenomics for a comprehensive understanding.
• To identify potential genetic markers for early prediction and personalized treatment of addiction, depression, eating disorders, schizophrenia, and PTSD.

Main Methods:

• Advocating for an integrative approach combining genomics and epigenomics.
• Evaluating the influence of epigenetic modifications on genes, neuropeptides, neurotransmitters, and hormones.
• Examining gene × gene and gene × environment interactions to identify contributing abnormalities.

Main Results:

• The study outlines a theoretical framework for novel genetic approaches.
• It highlights the potential of systems biology to uncover biological underpinnings.
• It suggests that identified markers could aid in early prediction and personalized therapy.

Conclusions:

• Novel genetic approaches integrating systems biology are crucial for understanding psychiatric disorders.
• This approach may lead to the identification of genetic markers for early detection and risk assessment.
• These markers could facilitate the development of novel disease subtypes and personalized treatment strategies.